The award, which is conferred at the discretion of the ASHP Board of Directors, may be presented annually at the ASHP national meeting or other appropriate function. There is no limit to the number of awards that may be conferred each year.
2025 Recipient
Virginia Department of Health (VDH) mpox Medical Countermeasures Unit
Richmond, Va.
Pharmacists at the VDH demonstrated substantial innovation, leadership, and guidance both during and following the 2022 outbreak of monkeypox (now known as mpox). Hospitals, health systems, state societies, and health departments across the country heavily relied on the consequential work of the VDH mpox team to inform their mpox initiatives. These resources continue to serve as a model for many within healthcare.
Criteria and Eligibility
ASHP members are invited, annually, to suggest nominees in writing with substantiating evidence. The award is intended to recognize an elected government official, public servant, or an organization whose involvement in public policy and advocacy supports the improvement of medication safety and health outcomes and the advancement of pharmacy practice. Support can be demonstrated either through a recent singular, significant achievement or for career-long contributions and accomplishments at the local, state, or national level. Examples include but are not limited to outstanding contributions to the visibility, value, and advancement of pharmacy practice and health policy through political and legislative activity, patient advocacy, civic leadership, and/or environmental stewardship with regard to ASHP’s strategic priorities and key advocacy issues.
Nominees may be pharmacists or non-pharmacists, regardless of practice area or ASHP membership status. Current ASHP Board members and ASHP staff are not eligible.
Nominating Instructions
Nominations are accepted year-round and are to be transmitted electronically during this period using the Award Nominations Form. Please see the Call for Award Nominations to reference the criteria for the award as well as the nomination instructions.
Nominations received by October 1 will be reviewed by the Awards Committee, and selections will be made the following February. In some years, selections are not made for all awards.
If you have any questions about the Awards Program, please contact the Office of Member Relations at [email protected].
Past Recipients
| 2024 | Magdi H. Awad, PharmD, MSA, RPh |
| 2024 | Dele Solaru, PharmD, MBA |
| 2023 | Alex J. Adams, PharmD, MPH |
| 2023 | Julie Groppi, PharmD, FASHP |
| 2022 | Representative Gary Merchant, MBA, RPh |
| 2022 | Colorado Pharmacists Society led coalition involved in the passage of H.B. 21-1275, Medicaid Reimbursement for Services by Pharmacists |
| 2021 | ADM Brett P. Giroir, MD |
| 2021 | Coalition of New Mexico pharmacy professionals involved in the passage of H.B. 42, Pharmaceutical Services Reimbursement Parity |
